Evidence map›Paper›PMID 29781340›Full record

ArticleDrug delivery2018

Graphene oxide enhances alginate encapsulated cells viability and functionality while not affecting the foreign body response.

Jesús Ciriza, Laura Saenz Del Burgo, Haritz Gurruchaga, Francesc E Borras, Marcella Franquesa, Gorka Orive, Rosa Maria Hernández, José Luis Pedraz

Open access · goldAbstract read
In one paragraph

Article in Drug delivery, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 29 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Graphene Oxide Normal (GO + MnAntioxidants (Basel, Switzerland) · 2021
    Article
  6. Article
  7. 3D Graphene Scaffolds for Skeletal Muscle Regeneration: Future Perspectives.Frontiers in bioengineering and biotechnology · 2020
    Review
  8. Current Status of Alginate in Drug Delivery.Advances in pharmacological and pharmaceutical sciences · 2020
    Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Jesús Cirizaa Biomedical Research Networking Center in Bioengineering, Biomaterials and Nanomedicine , CIBER-BBN , Vitoria-Gasteiz , Spain.ORCID http://orcid.org/0000-0002-8666-622X
Laura Saenz Del Burgoa Biomedical Research Networking Center in Bioengineering, Biomaterials and Nanomedicine , CIBER-BBN , Vitoria-Gasteiz , Spain.ORCID http://orcid.org/0000-0002-1766-1361
Haritz Gurruchagaa Biomedical Research Networking Center in Bioengineering, Biomaterials and Nanomedicine , CIBER-BBN , Vitoria-Gasteiz , Spain.
Francesc E Borrasc REMAR-IVECAT Group, Health Science Research Institute Germans Trias i Pujol , Badalona , Spain.ORCID http://orcid.org/0000-0003-4038-1912
Marcella Franquesac REMAR-IVECAT Group, Health Science Research Institute Germans Trias i Pujol , Badalona , Spain.
Gorka Orivea Biomedical Research Networking Center in Bioengineering, Biomaterials and Nanomedicine , CIBER-BBN , Vitoria-Gasteiz , Spain.
Rosa Maria Hernándeza Biomedical Research Networking Center in Bioengineering, Biomaterials and Nanomedicine , CIBER-BBN , Vitoria-Gasteiz , Spain.ORCID http://orcid.org/0000-0002-3947-409X
José Luis Pedraza Biomedical Research Networking Center in Bioengineering, Biomaterials and Nanomedicine , CIBER-BBN , Vitoria-Gasteiz , Spain.
University of the Basque Country · ESInstitut d'Investigació en Ciències de la Salut Germans Trias i Pujol · ESUniversitat Autònoma de Barcelona · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The combination of protein-coated graphene oxide (GO) and microencapsulation technology has moved a step forward in the challenge of improving long-term alginate encapsulated cell survival and sustainable therapeutic protein release, bringing closer its translation from bench to the clinic. Although this new approach in cell microencapsulation represents a great promise for long-term drug delivery, previous studies have been performed only with encapsulated murine C

Indexed as

AlginatesAnimalsCapsulesCell LineCell SurvivalDelayed-Action PreparationsDrug CompoundingDrug Delivery SystemsErythropoietinForeign BodiesGlucuronic AcidGraphiteHematocritHexuronic AcidsMesenchymal Stem CellsMiceAlginatesCapsulesDelayed-Action PreparationsErythropoietinGlucuronic AcidGraphiteHexuronic AcidsOxidescell microencapsulationerythropoietinGraphene oxideimmune responsestem cells

Identifiers

PMID29781340
PMCPMC6058697
OpenAlexW2803365615

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.